These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 4616070)

  • 61. [Serial influenza vaccination with a new subunit vaccine. Tolerance and effectiveness].
    Lutz O; Triebel R; Jahn P; Wiebe K; Schardt F; Kindt H
    Med Welt; 1978 Sep; 29(36):1412-5. PubMed ID: 682923
    [No Abstract]   [Full Text] [Related]  

  • 62. A new, surface-antigen-adsorbed influenza virus vaccine. I. Studies on immunogenicity in hamsters.
    Jennings R; Potter CW; McLaren C; Brady M
    J Hyg (Lond); 1975 Dec; 75(3):341-52. PubMed ID: 1059704
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Vaccines. Shifting tactics in the battle against influenza.
    Ault A
    Science; 2004 Feb; 303(5662):1280. PubMed ID: 14988531
    [No Abstract]   [Full Text] [Related]  

  • 64. [Influenza vaccination. The importance of antigen amount and adjuvant with reference to the humoral antibody formation after influenza vaccination. A comparative double-blind study with various vaccines].
    Sarateanu DE; Ehrengut W
    Fortschr Med; 1981 Sep; 99(34):1348-52. PubMed ID: 7026399
    [No Abstract]   [Full Text] [Related]  

  • 65. Universal influenza virus vaccines: need for clinical trials.
    Krammer F; Palese P
    Nat Immunol; 2014 Jan; 15(1):3-5. PubMed ID: 24352315
    [No Abstract]   [Full Text] [Related]  

  • 66. Neuraminidase antibodies and H5N1: geographic-dependent influenza epidemiology could determine cross-protection against emerging strains.
    Bermejo-Martin JF; Kelvin DJ; Guan Y; Chen H; Perez-Breña P; Casas I; Arranz E; de Lejarazu RO
    PLoS Med; 2007 Jun; 4(6):e212. PubMed ID: 17593897
    [No Abstract]   [Full Text] [Related]  

  • 67. [Prevention of grippe. Principles of vaccine manufacture].
    Brangier J
    Soins; 1982 Oct; (391):19-21. PubMed ID: 6925315
    [No Abstract]   [Full Text] [Related]  

  • 68. Can immunity induced by the human influenza virus N1 neuraminidase provide some protection from avian influenza H5N1 viruses?
    Gillim-Ross L; Subbarao K
    PLoS Med; 2007 Feb; 4(2):e91. PubMed ID: 17298170
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Infection defense antigens against pathogenic viruses to human. Infection defense antigens and genetic code--trend and progress of study on biomolecular analysis. a. Influenza viruses].
    Nobusawa E; Nakajima K
    Nihon Rinsho; 1987 Oct; 45(10):2229-34. PubMed ID: 3448262
    [No Abstract]   [Full Text] [Related]  

  • 70. Temperature-sensitive mutants of influenza virus. II. Attenuation of ts recombinants for man.
    Murphy BR; Chalhub EG; Nusinoff SR; Chanock RM
    J Infect Dis; 1972 Aug; 126(2):170-8. PubMed ID: 4626544
    [No Abstract]   [Full Text] [Related]  

  • 71. [Comparative analysis of influenza virus strains isolated in Poland during the epidemic season 1981-1982].
    Loza-Tulimowska M; Isaczenko WA; Lubowcewa OW; Iwanowa WT; Zakstelskaja LJ; Semkow RA
    Med Dosw Mikrobiol; 1984; 36(1):27-32. PubMed ID: 6738227
    [No Abstract]   [Full Text] [Related]  

  • 72. Overcoming challenges to influenza vaccination in patients with CKD.
    Kallen AJ; Fiore AE
    Am J Kidney Dis; 2009 Jul; 54(1):6-9. PubMed ID: 19559336
    [No Abstract]   [Full Text] [Related]  

  • 73. Influenza: recommendations for vaccination and treatment.
    Mihalopoulos NL; Khan A; Wiese J
    J La State Med Soc; 2001 Dec; 153(12):596-602. PubMed ID: 11804453
    [TBL] [Abstract][Full Text] [Related]  

  • 74. New influenza vaccine for 1974-1975.
    Med Lett Drugs Ther; 1974 Sep; 16(20):81-4. PubMed ID: 4427572
    [No Abstract]   [Full Text] [Related]  

  • 75. [Prophylactic effectiveness of an inactivated formol influenza vaccine].
    Agafonov VI; Perepelkin VS; Chemeris EA; Novikov NL
    Voen Med Zh; 1981 Feb; (2):36-8. PubMed ID: 7233843
    [No Abstract]   [Full Text] [Related]  

  • 76. Recombinant influenza-virus vaccines. III. Isolation and preliminary characterization of so-called antigenic recombinant influenza viruses.
    Higashihara M; Igarashi Y; Saito Y
    Kitasato Arch Exp Med; 1976 Sep; 49(3):67-79. PubMed ID: 1029758
    [No Abstract]   [Full Text] [Related]  

  • 77. Influenza. Epidemiology and prevention.
    Feery BJ
    Med J Aust; 1984 Jul; 141(2):78-9. PubMed ID: 6738439
    [No Abstract]   [Full Text] [Related]  

  • 78. Neuraminidases and hemagglutinins of influenza viruses augment cell-mediated cytotoxicity by activating NK cells.
    Sinkovics JG
    Nat Immun Cell Growth Regul; 1989; 8(3):187-8. PubMed ID: 2779600
    [No Abstract]   [Full Text] [Related]  

  • 79. Attenuated ts-recombinants of influenza A/USSR/77 (H1N1) virus obtained by crossing with the cold-adapted donor A/Leningrad/134/57 (H2N2) virus.
    Polezhaev FI; Garmashova LM; Koval TA; Taranova GP; Topuriya NV; Aleksandrova GI
    Acta Virol; 1982 Jul; 26(4):221-6. PubMed ID: 6127928
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Studies on a recombinant influenza A virus by indirect neutralization.
    Majer M; Link F
    Z Immunitatsforsch Exp Klin Immunol; 1972 Jul; 144(1):96-9. PubMed ID: 4283242
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.